Recruiting
Phase 2

Observational Study

Sponsor:

National Development and Research Institutes, Inc.

Code:

NCT00182572

Conditions

Opioid-Dependence Among Adolescents

Eligibility Criteria

Sex: All

Age: 13 - 18

Healthy Volunteers: Not accepted

Interventions

buprenorphine

naltrexone

behavior therapy

voucher-based contingency management

Study Details

Brief summary:

The purpose of this study is to evaluate ways to optimize outcomes from combined behavioral-pharmacological treatment for opioid-dependent youth.

Conditions

Opioid-Dependence Among Adolescents

Study ID

NCT00182572

Start date

Jul, 2005

Status verified date

Aug, 2008

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 13 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • clinical diagnosis of opioid dependence
  • ages 13-18 years

Exclusion Criteria:

  • active psychosis
  • active suicidality
  • major medical problems (e.g., cardiovascular disease)
  • pregnancy
  • require inpatient detoxification from non-opiate drugs

Study Design

Enrollment

80 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

buprenorphine

naltrexone

behavior therapy

voucher-based contingency management

Primary outcome measure

  • opiate use [ Time Frame: undefined ]

Central Contacts and Locations

Central contacts

Lisa Marsch, PhD

212-636-1253marsch@ndri.org

Ramon Solhkhah, MD

212-523-3069RSolhkha@chpnet.org

Locations

Behavioral Science Research Unit, St. Luke's Hospital

Recruiting

New York, New York, United States, 10025

Principal Investigator:

Lisa Marsch, PhD

More Information

Sponsor

National Development and Research Institutes, Inc.

Last update posted

Aug 12, 2008

Last verified

Aug, 2008

Keywords

  • heroin
  • opiate
  • addiction
  • adolescent
  • treatment

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Development and Research Institutes, Inc. on 2008-08-12.